Clinical Trials
58 trialsEarly-stage Detection of Liver Cancer by Proteins in Peripheral Blood
Second Affiliated Hospital, School of Medicine, Zhejiang University
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Hoffmann-La Roche
MONTEROSA
AstraZeneca
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
TEP CARE
University Hospital, Lille
TERMOMIRNA
IRCCS Azienda Ospedaliero-Universitaria di Bologna
A Comparative Study on the Diagnostic Efficacy of Ultrasound Contrast LI-RADS Grading and the German ESCULAP Standards for the Diagnosis of Recurrent Hepatic Mass Lesions After Hepatocellular Carcinoma Surgery
The First Hospital of Jilin University
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
HistoSonics, Inc.
CIRT
Cardiovascular and Interventional Radiological Society of Europe
Radiomics Subtyping to Guide Surgery vs. Maintenance Therapy After HCC Downstaging
First Affiliated Hospital, Sun Yat-Sen University
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
National Cancer Institute (NCI)
PLVT_TH
Assistance Publique - Hôpitaux de Paris
AI-Based Multimodal Integration for Tumor Microenvironment Analysis and Response Prediction in HCC Treated With TACE Plus Immunotherapy and Targeted Therapy (CHANCE2601)
Zhongda Hospital
Standing Position Ultrasonography: Imaging Efficacy in Detecting Liver Diaphragmatic Dome Blind Area Lesions
The First Hospital of Jilin University
HDL-CEUS-MRI
The First Hospital of Jilin University
Clinical Significance of Hepatic and Circulating microRNAs miR-221 and miR-222 in Hepatocellular Carcinoma
University of Aberdeen
Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis
Zhongda Hospital
Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without TACE for Advanced HCC With Vascular Invasions
Zhongda Hospital
Extracellular RNA Markers of Liver Disease and Cancer
Mayo Clinic
Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer
Shandong Cancer Hospital and Institute
HCC
Anhui Provincial Hospital
ELEPHAS-02
Elephas
BILIVER
Azienda USL Toscana Centro
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma
Tongji Hospital
MAGNUS-HCC
Seoul St. Mary's Hospital
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
National Institutes of Health Clinical Center (CC)
AI-Assisted Staging and Treatment Decision-Making for Hepatocellular Carcinoma
Beijing Tsinghua Chang Gung Hospital
CHANCE2202
Zhongda Hospital
CHANCE2201
Zhongda Hospital
CHALNA2
Institut National de la Santé Et de la Recherche Médicale, France
Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines
M.D. Anderson Cancer Center
TraveraRTGx
Travera Inc
Radiofrequency Ablation for Hepatocellular Carcinoma Using Octopus MP Electrodes
Seoul National University Hospital
ISTAR-01
Seoul National University Hospital
ISTAR-02
Seoul National University Hospital
ELUCIDATE
City of Hope Medical Center
VOCAL
Imperial College London
Optimizing Y90 Therapy for Radiation Lobectomy
Northwestern University
Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma
First Affiliated Hospital of Wenzhou Medical University
Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres
Methodist Health System
CCGLC-019
Tongji Hospital
Treat Primary and Metastatic Liver Tumors
Methodist Health System
cfDNA Methylation for Liver Cancer Recurrence Detection
Wuhan Ammunition Life-tech Co., Ltd
Evaluation of Resection Techniques for Pancreatic Tumors
Methodist Health System
QUS in HCC
Centre hospitalier de l'Université de Montréal (CHUM)
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Tel-Aviv Sourasky Medical Center
A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma
Zhongda Hospital
Individualized Surgical Guidance in HCC-BDTT
First Affiliated Hospital, Sun Yat-Sen University
ELEPHAS-04
Mayo Clinic